← Evidence map

ArticleFrontiers in immunology2026

The LVI Component Hypothesis: the lymphatic-to-vascular invasion ratio as an enrichment biomarker for therapy with PD-L1×VEGF-A bispecific antibodies.

Kenneth A KernPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The LVI Component Hypothesis: the lymphatic-to-vascular invasion ratio as an enrichment biomarker for therapy with PD-L1×VEGF-A bispecific antibodies. | OpenQuestion